AKT1 and colonic neoplasm: Later mechanistic studies indicated that celecoxib exhibits proapoptotic effects by inhibiting 3-phosphoinositide-dependent kinase-1 (PDK-1) and the downstream protein kinase B (Akt) signaling pathway in human colon cancer cells [16].